Canviiy’s brand DNA presents a fresh perspective in the healthcare industry, as the brand delivers products with integrity, solutions inspired by innovative plant science and committed to safe efficacious performance. The uniqueness of the brand thrives on the core premise of developing natural-based solutions to address niche, yet prevalent unmet patient needs. LaWanda Byrd, Director of Volunteer Services of Moffitt Cancer Center said “At Moffitt, we are closely attuned to the needs of our patients and one of those needs are to provide organic, hair and scalp care products. Therefore, we are incredibly proud to partner with Canviiy, as their natural-based solutions have proven to be effective across our patient population.”
With a team of organic experts and a strong desire for effective solutions, Canviiy pioneered the ScalpBliss™Collection, proven to be the most long-lasting (hours to days) organic-based scalp irritation solutions on the market today. All products are cruelty free, and free of parabens, sulfates, phthalates, steroids, zinc pyrithione, artificial fragrance and color. Tasha Swafford, Salon Supervisor of Moffitt’s Magnolia Salon said “The ScalpBliss Itch-Calming Serum really calms the scalp drastically reducing pain and discomfort as well as itching from the scalp. Most products require frequent application, however ScalpBliss effects lasts for days. The Scalp-Purifying Foam Treatment allows patients to comfortably and effectively remove dead skin cells as well as medications secreted on the scalp with ease.”
“Our partnership with Moffitt has been able to validate insights such as the brand’s product effectiveness against scalp irritation and the longevity of which patient relief lasts and has certainly open doors for the brand.” Sampson said. Canviiy officially formed a partnership with Moffitt Cancer Center in January 2018 and continues to work closely with internal teams to enhance scalp health for the entire patient population. Moffitt is recognized by US News & World Reports as a top hosipital in the cancer treatment speciality.